TY  - JOUR 
AU  - Apellaniz-Ruiz, Maria
AU  - Barrachina, Jordi
AU  - Castro-Sanchez, Paula
AU  - Comes-Raga, Ana
AU  - García-González, Xandra
AU  - Gil-Rodriguez, Almudena
AU  - Lopez-Lopez, Elixabet
AU  - Maroñas, Olalla
AU  - Morón, Rocío
AU  - Muriel, Javier
AU  - Olivera, Gladys G.
AU  - Riera, Pau
AU  - Saiz-Rodríguez, Miriam
AU  - Salvador-Martín, Sara
AU  - Sans-Pola, Carla
AU  - Tejera-Pérez, Hugo
AU  - Velasco-Ruiz, Alejandro
AU  - Verde, Zoraida
AU  - Wang, Daniel
AU  - Rodríguez-Vicente, Ana E.
AU  - Nunez-Torres, Rocio
PY  - 2025
UR  - https://hdl.handle.net/10259/11910
AB  - Introduction: Pharmacogenetics (PGx) has the potential to improve patient care, allowing to transform medical interventions by providing personalized therapeutic strategies. Scientific evidence supports the use of PGx in clinical practice and...
LA  - eng
KW  - Clinical implementation
KW  - Personalized medicine
KW  - Pharmacogenetics
KW  - Pharmacogenomics
KW  - Spanish national healthcare system
KW  - Medicina personalizada
KW  - Precision medicine
KW  - Farmacogenómica
KW  - Pharmacogenomics
TI  - Status of the implementation of pharmacogenetics in clinical practice in Spain: from regional to national initiatives
DO  - 10.1515/dmpt-2024-0042
T2  - Drug Metabolism and Personalized Therapy
VL  - 39
M2  - 183
ER  -